CME Group vs Rocket Companies
Add, change or remove companies; up to four.
The short version
- Rocket Companies is the larger business, with $6.7B of revenue in fiscal 2025 against $6.5B for CME Group.
- Rocket Companies grew revenue faster (31.3%, against 6.4%).
- CME Group turned more of its sales into free cash flow (64.3% FCF margin, against −60.0%).
| Latest fiscal year | CME · FY25 | RKT · FY25 |
|---|---|---|
| Size | ||
| Market cap | $109.6B | $33.4B |
| Revenue | $6.5B | $6.7B |
| Free cash flow | $4.2B | −$4.0B |
| Net income | $4.1B | −$68.0M |
| Growth | ||
| Revenue growth | 6.4% | 31.3% |
| 5-year growth | 6.0% | −15.6% |
| Share count change | 0.1% | 837.6% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | 64.9% | — |
| Net margin | 62.5% | −1.0% |
| FCF margin | 64.3% | −60.0% |
| Return on capital | 11.9% | — |
| Return on equity | 14.8% | −0.4% |
| Balance sheet | ||
| Net debt | −$1.1B | — |
| Net debt / EBITDA | −0.3x | — |
| Dividends and buybacks | $3.9B | $0.0M |
| Valuation & quality | ||
| P/E | 25.1x | — |
| Piotroski F-score | 7 | — |
FY16
CME $3.6B
RKT —
FY17
CME $3.6B
RKT —
FY18
CME $4.3B
RKT $4.2B
FY19
CME $4.9B
RKT $5.1B
FY20
CME $4.9B
RKT $15.7B
FY21
CME $4.7B
RKT $12.9B
FY22
CME $5.0B
RKT $5.8B
FY23
CME $5.6B
RKT $3.8B
FY24
CME $6.1B
RKT $5.1B
FY25
CME $6.5B
RKT $6.7B
CME
RKT
FY16
CME 61.2%
RKT —
FY17
CME 63.4%
RKT —
FY18
CME 60.5%
RKT —
FY19
CME 53.2%
RKT —
FY20
CME 54.0%
RKT —
FY21
CME 56.4%
RKT —
FY22
CME 60.1%
RKT —
FY23
CME 61.6%
RKT —
FY24
CME 64.1%
RKT —
FY25
CME 64.9%
RKT —
CME
RKT
FY16
CME $1.6B
RKT —
FY17
CME $1.7B
RKT —
FY18
CME $2.3B
RKT $1.4B
FY19
CME $2.4B
RKT −$7.0B
FY20
CME $2.5B
RKT −$1.8B
FY21
CME $2.3B
RKT $7.6B
FY22
CME $3.0B
RKT $10.7B
FY23
CME $3.4B
RKT $51.0M
FY24
CME $3.6B
RKT −$2.7B
FY25
CME $4.2B
RKT −$4.0B
CME
RKT
FY16
CME 7.1%
RKT —
FY17
CME 10.7%
RKT —
FY18
CME 7.2%
RKT —
FY19
CME 7.1%
RKT —
FY20
CME 7.2%
RKT —
FY21
CME 7.3%
RKT —
FY22
CME 8.3%
RKT —
FY23
CME 9.8%
RKT —
FY24
CME 11.3%
RKT —
FY25
CME 11.9%
RKT —
CME
RKT
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.